Join us in our mission
We are a team of passionate individuals powered by technology, guided by scientific research, and driven by collaboration — working to cure or prevent all disease.
Expand your research with a grant
We support science through targeted grantmaking and open competition in our areas of frontier research.
Funding opportunities
Science Ventures
We invest globally in innovative, early-stage companies that support and accelerate our Grand Challenges. Recent investments include Somite AI, which is building foundational AI models for cell therapy development and Adaptyx Biosciences, which is developing continuous, multi-analyte molecular monitoring.
Meetings and Events
-
New YorkJuly 22–23, 2026
New York Symposium on Immune Cell Engineering and Reprogramming
Join us for the 1st New York Symposium on Immune Cell Engineering and Reprogramming, showcasing advances in immunology, synthetic biology, bioengineering, and AI.
-
ChicagoSeptember 17–18, 2026
Chicago BioEngineering Conference (CBEC) 2026
Join us for the 2nd Chicago BioEngineering Conference, showcasing high-throughput omics, spatial and live tissue omics, bioelectronics, and AI x Bio.
Meetings and events
Biohub carries out its work through Chan Zuckerberg Biohub, Inc. (a 501(c)(3) medical research organization); Chan Zuckerberg Initiative, LLC (which provides strategic, funding, and operational support); Chan Zuckerberg Initiative Foundation (a 501(c)(3) private foundation); and the Biohub Donor Advised Fund. These individuals serve as the Board of Directors and officers of Chan Zuckerberg Biohub, Inc., a 501(c)(3) medical research organization.